Michael Schelle currently serves as the Executive Vice President at Remedy Plan Therapeutics and works as a Biotech Consultant for Early Stage Startups. Prior experience includes holding the role of Vice President of Research and Operations, as well as Head of Operations and Corporate Strategy at Acrigen Biosciences. Michael's earlier positions featured significant contributions at Ripple Foods, where responsibilities spanned from Leading New Product Innovation and Commercialization to building a data-driven Analytics team. Additionally, Michael was a Senior Scientist at DuPont Industrial Biosciences, contributing to enzyme product development, and held the position of Laboratory Director at UC Berkeley’s BSL3 facility. Michael earned a Ph.D. in Chemistry from the University of California, Berkeley, and a B.S. in Chemistry from Butler University.
Sign up to view 0 direct reports
Get started
This person is not in any teams
This person is not in any offices